Collagen V α1 Chain Decrease in Papillary Dermis from Early Systemic Sclerosis: A New Proposal in Cutaneous Fibrosis Molecular Structure

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Oct 27

PMID 36293511

Authors

Jymenez de Morais

Ana Paula P Velosa

Priscila C Andrade

Denise Frediani

Solange Carrasco

Zelita A de Jesus Queiroz

Patricia Martin

Renata F Saito

Vitoria Elias

Claudia Goldenstein-Schainberg

Roger Chammas

Percival D Sampaio-Barros

Vera L Capelozzi

Walcy R Teodoro

Affiliations

Soon will be listed here.

Abstract

Cutaneous fibrosis is one of the main features of systemic sclerosis (SSc). Recent findings correlated abnormal collagen V (Col V) deposition in dermis with skin thickening and disease activity in SSc. Considering that Col V is an important regulator of collagen fibrillogenesis, understanding the role of Col V in the first two years of the skin fibrosis in SSc (early SSc) can help to determine new targets for future treatments. In this study, we analyzed the morphological, ultrastructural and molecular features of α1(V) and α2(V) chains and the expression of their coding genes COL5A1 and COL5A2 in collagen fibrillogenesis in early-SSc. Skin biopsies were obtained from seven consecutive treatment-naïve patients with SSc-related fibrosis and four healthy controls. Our data showed increased α1(V) and α2(V) chain expression in the reticular dermis of early-SSc patients; however, immunofluorescence and ultrastructural immunogold staining determined a significant decreased expression of the α1(V) chain along the dermoepidermal junction in the papillary dermis from early-SSc-patients in relation to the control (12.77 ± 1.34 vs. 66.84 ± 3.36; p < 0.0001). The immunoblot confirmed the decreased expression of the α1(V) chain by the cutaneous fibroblasts of early-SSc, despite the increased COL5A1 and COL5A2 gene expression. In contrast, the α2(V) chain was overexpressed in the small vessels (63.18 ± 3.56 vs. 12.16 ± 0.81; p < 0.0001) and capillaries (60.88 ± 5.82 vs. 15.11 ± 3.80; p < 0.0001) in the reticular dermis of early-SSc patients. Furthermore, COLVA2 siRNA in SSc cutaneous fibroblasts resulted in a decreased α1(V) chain expression. These results highlight an intense decrease in the α1(V) chain along the dermoepidermal junction, suggesting an altered molecular histoarchitecture in the SSc papillary dermis, with a possible decrease in the expression of the α1(V)3 homotrimeric isoform, which could interfere with the thickening and cutaneous fibrosis related to SSc.

References

Janson D, Saintigny G, Zeypveld J, Mahe C, El Ghalbzouri A . TGF-β1 induces differentiation of papillary fibroblasts to reticular fibroblasts in monolayer culture but not in human skin equivalents. Eur J Dermatol. 2014; 24(3):342-8. DOI: 10.1684/ejd.2014.2312. View

Zeltz C, Gullberg D . The integrin-collagen connection--a glue for tissue repair?. J Cell Sci. 2016; 129(4):653-64. DOI: 10.1242/jcs.180992. View

Henderson J, Distler J, OReilly S . The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target. Trends Mol Med. 2019; 25(5):395-411. DOI: 10.1016/j.molmed.2019.02.001. View

Chanut-Delalande H, Bonod-Bidaud C, Cogne S, Malbouyres M, Ramirez F, Fichard A . Development of a functional skin matrix requires deposition of collagen V heterotrimers. Mol Cell Biol. 2004; 24(13):6049-57. PMC: 480903. DOI: 10.1128/MCB.24.13.6049-6057.2004. View

Ishikawa Y, Taga Y, Zientek K, Mizuno N, Salo A, Semenova O . Type I and type V procollagen triple helix uses different subsets of the molecular ensemble for lysine posttranslational modifications in the rER. J Biol Chem. 2021; 296:100453. PMC: 7988497. DOI: 10.1016/j.jbc.2021.100453. View

Teodoro W, Queiroz Z, Dos Santos L, Catanozi S, Dos Santos Filho A, Bueno C . Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity. Arthritis Res Ther. 2019; 21(1):278. PMC: 6907238. DOI: 10.1186/s13075-019-2052-2. View

Steen V, Medsger Jr T . Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000; 43(11):2437-44. DOI: 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Querfeld C, Eckes B, Huerkamp C, Krieg T, Sollberg S . Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma. J Dermatol Sci. 1999; 21(1):13-22. DOI: 10.1016/s0923-1811(99)00008-0. View

10.

Mak K, Png C, Lee D . Type V Collagen in Health, Disease, and Fibrosis. Anat Rec (Hoboken). 2016; 299(5):613-29. DOI: 10.1002/ar.23330. View

11.

Tsou P, Varga J, OReilly S . Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential. Nat Rev Rheumatol. 2021; 17(10):596-607. DOI: 10.1038/s41584-021-00683-2. View

12.

Valentini G, Silman A, Veale D . Assessment of disease activity. Clin Exp Rheumatol. 2003; 21(3 Suppl 29):S39-41. View

13.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

14.

Zurita-Salinas C, Krotzsch E, Diaz de Leon L, Alcocer-Varela J . Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis. Rheumatol Int. 2003; 24(5):283-90. DOI: 10.1007/s00296-003-0364-6. View

15.

Liu T, Zhang J . [Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008; 39(5):748-52. View

16.

Pachera E, Assassi S, Salazar G, Stellato M, Renoux F, Wunderlin A . Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosis. J Clin Invest. 2020; 130(9):4888-4905. PMC: 7456219. DOI: 10.1172/JCI135439. View

17.

Skaug B, Khanna D, Swindell W, Hinchcliff M, Frech T, Steen V . Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis. 2019; 79(3):379-386. PMC: 7386329. DOI: 10.1136/annrheumdis-2019-215894. View

18.

Parra E, Aguiar Jr A, Teodoro W, de Souza R, Yoshinari N, Capelozzi V . Collagen V and vascular injury promote lung architectural changes in systemic sclerosis. Clin Respir J. 2010; 3(3):135-42. DOI: 10.1111/j.1752-699X.2008.00118.x. View

19.

Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R . Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995; 22(7):1281-5. View

20.

Denton C, Khanna D . Systemic sclerosis. Lancet. 2017; 390(10103):1685-1699. DOI: 10.1016/S0140-6736(17)30933-9. View